A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study
- PMID: 16162459
- DOI: 10.1080/14653240500238160
A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study
Abstract
HLA-matched UC blood-derived multipotent stem cells were directly transplanted into the injured spinal cord site of a 37-year-old female patient suffering from spinal cord injury (SPI). In this case, human cord blood (UCB)-derived multipotent stem cells improved sensory perception and movement in the SPI patient's hips and thighs within 41 days of cell transplantation. CT and MRI results also showed regeneration of the spinal cord at the injured site and some of the cauda equina below it. Therefore, it is suggested that UCB multipotent stem cell transplantation could be a good treatment method for SPI patients.
Similar articles
-
Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury.Exp Neurol. 2008 Feb;209(2):510-22. doi: 10.1016/j.expneurol.2007.09.031. Epub 2007 Oct 12. Exp Neurol. 2008. PMID: 18029281
-
Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery.Surg Neurol. 2008 Dec;70(6):600-7; discussion 607. doi: 10.1016/j.surneu.2007.09.043. Epub 2008 Mar 4. Surg Neurol. 2008. PMID: 18291482
-
Long-term culture and neuronal survival after intraspinal transplantation of human spinal cord-derived neurospheres.Physiol Behav. 2007 Sep 10;92(1-2):60-6. doi: 10.1016/j.physbeh.2007.05.056. Epub 2007 May 25. Physiol Behav. 2007. PMID: 17610915
-
The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration.Exp Hematol. 2007 Dec;35(12):1753-65. doi: 10.1016/j.exphem.2007.08.017. Epub 2007 Oct 18. Exp Hematol. 2007. PMID: 17949892 Review.
-
[Transplantation of neural stem cells for spinal cord injury].Rinsho Shinkeigaku. 2005 Nov;45(11):874-6. Rinsho Shinkeigaku. 2005. PMID: 16447750 Review. Japanese.
Cited by
-
Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.Stem Cell Res Ther. 2024 Jul 29;15(1):234. doi: 10.1186/s13287-024-03830-0. Stem Cell Res Ther. 2024. PMID: 39075614 Free PMC article. Review.
-
Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case report.Front Transplant. 2023 Dec 7;2:1287508. doi: 10.3389/frtra.2023.1287508. eCollection 2023. Front Transplant. 2023. PMID: 38993875 Free PMC article.
-
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency.Biomolecules. 2024 Feb 19;14(2):242. doi: 10.3390/biom14020242. Biomolecules. 2024. PMID: 38397479 Free PMC article. Review.
-
Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury.Int J Mol Sci. 2021 Dec 20;22(24):13672. doi: 10.3390/ijms222413672. Int J Mol Sci. 2021. PMID: 34948463 Free PMC article. Review.
-
Stem Cell Therapy for Spinal Cord Injury.Cell Transplant. 2021 Jan-Dec;30:963689721989266. doi: 10.1177/0963689721989266. Cell Transplant. 2021. PMID: 33559479 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials